Serum Phenylacetylglutamine Is a Potential Risk Factor for Aortic Stiffness in Patients with Chronic Hemodialysis
<b>Background/Objectives:</b> Phenylacetylglutamine (PAG), a gut microbiota-derived metabolite, may contribute to the development of cardiometabolic diseases. The diagnostic value of PAG for vascular dysfunction in hemodialysis (HD) remains unclear. This study assessed how serum PAG levels relate to...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
MDPI AG
2025-12-01
|
| 丛编: | Diagnostics |
| 主题: | |
| 在线阅读: | https://www.mdpi.com/2075-4418/15/24/3123 |
| 标签: |
没有标签, 成为第一个标记此记录!
|